Ovid Therapeutics Inc. — Form D
Ovid Therapeutics Inc. of New York, NY, a company, filed a Form D exempt-offering notice with the SEC on 2015-03-18. The offering totals $5.1M, of which $5.1M was reported sold. Industry: Other Technology.
Offering
- Filed: 2015-03-18
- Form: D
- Accession: 0001140361-15-012509
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $5.1M
- Amount sold: $5.1M
- Investors: 5
- Date of first sale: 2014-10-10
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-236187
Issuer
- Name: Ovid Therapeutics Inc.
- CIK: 0001636651
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 1460 Broadway, New York, NY, 10036
- Phone: 646-661-7661
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Mark M Feldberg | Director | New York, NY |
| Amit E Rakhit | Executive Officer | New York, NY |
| Bart M Friedman | Director | New York, NY |
| Yaron M Werber | Executive Officer | New York, NY |
| Jeremy M Levin | Director | New York, NY |
| Jeremy M Levin | Executive Officer | New York, NY |
| Douglas E Williams | Director | New York, NY |
| Karen E Bernstein | Director | New York, NY |
| Matthew J During | Director | New York, NY |
| Matthew J During | Executive Officer | New York, NY |
Other filings by this issuer (2)
More